WHO criteria for overt primary myelofibrosis
Major criteria
Presence of megakaryocytic proliferation and atypia, accompanied by either reticulin and/or collagen fibrosis grades 2 or 3
Not meeting the WHO criteria for essential thrombocythemia, polycythemia vera, BCR-ABL11 chronic myeloid leukemia, myelodysplastic syndromes, or other myeloid neoplasms
Presence of JAK2, CALR, or MPL mutation or in the absence of these mutations, presence of another clonal marker, or absence of reactive myelofibrosis
Minor criteria (presence confirmed in 2 consecutive determinations)
Palpable splenomegaly
Anemia not attributed to a comorbid condition
WBC count ≥ 11×10⁹/L
LDH increased to above upper normal limit of institutional reference range
Leukoerythroblastosis
Diagnostic criteria are not met
Reference
Daniel A Arber, Attilio Orazi, Robert Hasserjian et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 May 19;127(20):2391-405.
Open reference URL